These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5922724)

  • 1. [Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline].
    Bock KD; Heimsoth V; Merguet P; Schönermark J
    Dtsch Med Wochenschr; 1966 Oct; 91(40):1761-70. PubMed ID: 5922724
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ophthalmological studies with dichlorophenylaminoimidazoline with special regard to its effect on intraocular pressure].
    Makabe R
    Dtsch Med Wochenschr; 1966 Sep; 91(38):1686-8. PubMed ID: 5917871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies on differential therapy of hypertension with dichlorophenylaminoimidazoline hydrochloride (Haemiton)].
    Seifert A; Hafemeister G; Kirchner D; Wöstenberg D; Tiedcke H; Ullmann W
    Dtsch Gesundheitsw; 1970 Dec; 25(50):2369-74. PubMed ID: 5509665
    [No Abstract]   [Full Text] [Related]  

  • 5. [First observations on an antihypertensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in man].
    Michel D; Zimmermann W; Nassehi A; Seraphim P
    Dtsch Med Wochenschr; 1966 Sep; 91(35):1540-7. PubMed ID: 5917865
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].
    Grabner G; Michalek P; Pokorny D; Vormittag E
    Arzneimittelforschung; 1966 Sep; 16(9):1174-9. PubMed ID: 6014738
    [No Abstract]   [Full Text] [Related]  

  • 7. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
    Fritsch H; Bachmann GW; Lenhard J
    Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
    [No Abstract]   [Full Text] [Related]  

  • 8. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the blood pressure lowering effect of cyclazenin and a cyclazenin-alpha-methyldopa combination].
    Seige K; Preuss EG; Mörl H; Köhler I; Lantzsch W
    Med Welt; 1969 Mar; 10():520-6. PubMed ID: 5772239
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic examination and studies on renal function with a new antihypertensive agent (St 155)].
    Frank H; von Loewenich-Lagois K
    Dtsch Med Wochenschr; 1966 Sep; 91(38):1680-6. PubMed ID: 5917870
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients.
    Sung PK; Samet P; Yeh BK
    Curr Ther Res Clin Exp; 1971 May; 13(5):280-5. PubMed ID: 4998390
    [No Abstract]   [Full Text] [Related]  

  • 12. Some aspects of the management of hypertension II. Special considerations.
    Rowe WS
    Med J Aust; 1975 Mar; 1(10):307-8. PubMed ID: 1128344
    [No Abstract]   [Full Text] [Related]  

  • 13. [Water-sodium depletion and clonidine in severe arterial hypertension].
    Sobel A; Safar M; Milliez P
    Maroc Med; 1972 Apr; 52(556):187-92. PubMed ID: 5042074
    [No Abstract]   [Full Text] [Related]  

  • 14. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
    Borrello G
    Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with a new hypotensive substance].
    Kühns K; Janocha U; Janocha C; Magnus D
    Munch Med Wochenschr; 1965 Dec; 107(51):2599-602. PubMed ID: 5331065
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with a new salureticum in essential hypertension].
    Hammer O; Dembowski U
    Med Klin; 1969 Oct; 64(41):1862-4. PubMed ID: 5397042
    [No Abstract]   [Full Text] [Related]  

  • 17. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine (Catapres): a new antihypertensive agent.
    Khan A; Camel G; Perry HM
    Curr Ther Res Clin Exp; 1970 Jan; 12(1):10-8. PubMed ID: 4984047
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical studies with a new antihypertensive agent, Bendigon].
    Wardemann H
    Med Welt; 1970 Sep; 37():1617-20. PubMed ID: 5526791
    [No Abstract]   [Full Text] [Related]  

  • 20. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
    Bergström J; Bergquist-Poppen M; Bucht H
    Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.